Global Anti-influenza Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4869055
- 88 Pages
- February 2022
- Medical Devices
The United States Anti-influenza Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anti-influenza Drugs market, reaching US$ million by the year 2028. As for the Europe Anti-influenza Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Anti-influenza Drugs players cover Roche, HEC Pharm, Shanghai Zhongxisanwei, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-influenza Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oseltamivir
Zanamivir
Peramivir
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Children
Adults
Elderly
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
HEC Pharm
Shanghai Zhongxisanwei
GlaxoSmithKline
Guangzhou Pharmaceutical
Hunan Nucien Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-influenza Drugs Market Size 2017-2028
2.1.2 Anti-influenza Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Anti-influenza Drugs Segment by Type
2.2.1 Oseltamivir
2.2.2 Zanamivir
2.2.3 Peramivir
2.2.4 Other
2.3 Anti-influenza Drugs Market Size by Type
2.3.1 Anti-influenza Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Anti-influenza Drugs Market Size Market Share by Type (2017-2022)
2.4 Anti-influenza Drugs Segment by Application
2.4.1 Children
2.4.2 Adults
2.4.3 Elderly
2.5 Anti-influenza Drugs Market Size by Application
2.5.1 Anti-influenza Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Anti-influenza Drugs Market Size Market Share by Application (2017-2022)
3 Anti-influenza Drugs Market Size by Player
3.1 Anti-influenza Drugs Market Size Market Share by Players
3.1.1 Global Anti-influenza Drugs Revenue by Players (2020-2022)
3.1.2 Global Anti-influenza Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Anti-influenza Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anti-influenza Drugs by Regions
4.1 Anti-influenza Drugs Market Size by Regions (2017-2022)
4.2 Americas Anti-influenza Drugs Market Size Growth (2017-2022)
4.3 APAC Anti-influenza Drugs Market Size Growth (2017-2022)
4.4 Europe Anti-influenza Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Anti-influenza Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Anti-influenza Drugs Market Size by Country (2017-2022)
5.2 Americas Anti-influenza Drugs Market Size by Type (2017-2022)
5.3 Americas Anti-influenza Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-influenza Drugs Market Size by Region (2017-2022)
6.2 APAC Anti-influenza Drugs Market Size by Type (2017-2022)
6.3 APAC Anti-influenza Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anti-influenza Drugs by Country (2017-2022)
7.2 Europe Anti-influenza Drugs Market Size by Type (2017-2022)
7.3 Europe Anti-influenza Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-influenza Drugs by Region (2017-2022)
8.2 Middle East & Africa Anti-influenza Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Anti-influenza Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Anti-influenza Drugs Market Forecast
10.1 Global Anti-influenza Drugs Forecast by Regions (2023-2028)
10.1.1 Global Anti-influenza Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Anti-influenza Drugs Forecast
10.1.3 APAC Anti-influenza Drugs Forecast
10.1.4 Europe Anti-influenza Drugs Forecast
10.1.5 Middle East & Africa Anti-influenza Drugs Forecast
10.2 Americas Anti-influenza Drugs Forecast by Country (2023-2028)
10.2.1 United States Anti-influenza Drugs Market Forecast
10.2.2 Canada Anti-influenza Drugs Market Forecast
10.2.3 Mexico Anti-influenza Drugs Market Forecast
10.2.4 Brazil Anti-influenza Drugs Market Forecast
10.3 APAC Anti-influenza Drugs Forecast by Region (2023-2028)
10.3.1 China Anti-influenza Drugs Market Forecast
10.3.2 Japan Anti-influenza Drugs Market Forecast
10.3.3 Korea Anti-influenza Drugs Market Forecast
10.3.4 Southeast Asia Anti-influenza Drugs Market Forecast
10.3.5 India Anti-influenza Drugs Market Forecast
10.3.6 Australia Anti-influenza Drugs Market Forecast
10.4 Europe Anti-influenza Drugs Forecast by Country (2023-2028)
10.4.1 Germany Anti-influenza Drugs Market Forecast
10.4.2 France Anti-influenza Drugs Market Forecast
10.4.3 UK Anti-influenza Drugs Market Forecast
10.4.4 Italy Anti-influenza Drugs Market Forecast
10.4.5 Russia Anti-influenza Drugs Market Forecast
10.5 Middle East & Africa Anti-influenza Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Anti-influenza Drugs Market Forecast
10.5.2 South Africa Anti-influenza Drugs Market Forecast
10.5.3 Israel Anti-influenza Drugs Market Forecast
10.5.4 Turkey Anti-influenza Drugs Market Forecast
10.5.5 GCC Countries Anti-influenza Drugs Market Forecast
10.6 Global Anti-influenza Drugs Forecast by Type (2023-2028)
10.7 Global Anti-influenza Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Anti-influenza Drugs Product Offered
11.1.3 Roche Anti-influenza Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 HEC Pharm
11.2.1 HEC Pharm Company Information
11.2.2 HEC Pharm Anti-influenza Drugs Product Offered
11.2.3 HEC Pharm Anti-influenza Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 HEC Pharm Main Business Overview
11.2.5 HEC Pharm Latest Developments
11.3 Shanghai Zhongxisanwei
11.3.1 Shanghai Zhongxisanwei Company Information
11.3.2 Shanghai Zhongxisanwei Anti-influenza Drugs Product Offered
11.3.3 Shanghai Zhongxisanwei Anti-influenza Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Shanghai Zhongxisanwei Main Business Overview
11.3.5 Shanghai Zhongxisanwei Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Anti-influenza Drugs Product Offered
11.4.3 GlaxoSmithKline Anti-influenza Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 Guangzhou Pharmaceutical
11.5.1 Guangzhou Pharmaceutical Company Information
11.5.2 Guangzhou Pharmaceutical Anti-influenza Drugs Product Offered
11.5.3 Guangzhou Pharmaceutical Anti-influenza Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Guangzhou Pharmaceutical Main Business Overview
11.5.5 Guangzhou Pharmaceutical Latest Developments
11.6 Hunan Nucien Pharmaceutical
11.6.1 Hunan Nucien Pharmaceutical Company Information
11.6.2 Hunan Nucien Pharmaceutical Anti-influenza Drugs Product Offered
11.6.3 Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Hunan Nucien Pharmaceutical Main Business Overview
11.6.5 Hunan Nucien Pharmaceutical Latest Developments
12 Research Findings and Conclusion
Table 1. Anti-influenza Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oseltamivir
Table 3. Major Players of Zanamivir
Table 4. Major Players of Peramivir
Table 5. Major Players of Other
Table 6. Anti-influenza Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Anti-influenza Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Anti-influenza Drugs Market Size Market Share by Type (2017-2022)
Table 9. Anti-influenza Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Anti-influenza Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Anti-influenza Drugs Market Size Market Share by Application (2017-2022)
Table 12. Global Anti-influenza Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Anti-influenza Drugs Revenue Market Share by Player (2020-2022)
Table 14. Anti-influenza Drugs Key Players Head office and Products Offered
Table 15. Anti-influenza Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Anti-influenza Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Anti-influenza Drugs Market Size Market Share by Regions (2017-2022)
Table 20. Americas Anti-influenza Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Anti-influenza Drugs Market Size Market Share by Country (2017-2022)
Table 22. Americas Anti-influenza Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Anti-influenza Drugs Market Size Market Share by Type (2017-2022)
Table 24. Americas Anti-influenza Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Anti-influenza Drugs Market Size Market Share by Application (2017-2022)
Table 26. APAC Anti-influenza Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Anti-influenza Drugs Market Size Market Share by Region (2017-2022)
Table 28. APAC Anti-influenza Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Anti-influenza Drugs Market Size Market Share by Type (2017-2022)
Table 30. APAC Anti-influenza Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Anti-influenza Drugs Market Size Market Share by Application (2017-2022)
Table 32. Europe Anti-influenza Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Anti-influenza Drugs Market Size Market Share by Country (2017-2022)
Table 34. Europe Anti-influenza Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Anti-influenza Drugs Market Size Market Share by Type (2017-2022)
Table 36. Europe Anti-influenza Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Anti-influenza Drugs Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Anti-influenza Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Anti-influenza Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Anti-influenza Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Anti-influenza Drugs
Table 45. Key Market Challenges & Risks of Anti-influenza Drugs
Table 46. Key Industry Trends of Anti-influenza Drugs
Table 47. Global Anti-influenza Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Anti-influenza Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Anti-influenza Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Anti-influenza Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Anti-influenza Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Anti-influenza Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 53. Roche Details, Company Type, Anti-influenza Drugs Area Served and Its Competitors
Table 54. Roche Anti-influenza Drugs Product Offered
Table 55. Roche Anti-influenza Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. HEC Pharm Details, Company Type, Anti-influenza Drugs Area Served and Its Competitors
Table 59. HEC Pharm Anti-influenza Drugs Product Offered
Table 60. HEC Pharm Main Business
Table 61. HEC Pharm Anti-influenza Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. HEC Pharm Latest Developments
Table 63. Shanghai Zhongxisanwei Details, Company Type, Anti-influenza Drugs Area Served and Its Competitors
Table 64. Shanghai Zhongxisanwei Anti-influenza Drugs Product Offered
Table 65. Shanghai Zhongxisanwei Main Business
Table 66. Shanghai Zhongxisanwei Anti-influenza Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Shanghai Zhongxisanwei Latest Developments
Table 68. GlaxoSmithKline Details, Company Type, Anti-influenza Drugs Area Served and Its Competitors
Table 69. GlaxoSmithKline Anti-influenza Drugs Product Offered
Table 70. GlaxoSmithKline Main Business
Table 71. GlaxoSmithKline Anti-influenza Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. GlaxoSmithKline Latest Developments
Table 73. Guangzhou Pharmaceutical Details, Company Type, Anti-influenza Drugs Area Served and Its Competitors
Table 74. Guangzhou Pharmaceutical Anti-influenza Drugs Product Offered
Table 75. Guangzhou Pharmaceutical Main Business
Table 76. Guangzhou Pharmaceutical Anti-influenza Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Guangzhou Pharmaceutical Latest Developments
Table 78. Hunan Nucien Pharmaceutical Details, Company Type, Anti-influenza Drugs Area Served and Its Competitors
Table 79. Hunan Nucien Pharmaceutical Anti-influenza Drugs Product Offered
Table 80. Hunan Nucien Pharmaceutical Main Business
Table 81. Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Hunan Nucien Pharmaceutical Latest Developments
List of Figures
Figure 1. Anti-influenza Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-influenza Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Anti-influenza Drugs Market Size Market Share by Type in 2021
Figure 7. Anti-influenza Drugs in Children
Figure 8. Global Anti-influenza Drugs Market: Children (2017-2022) & ($ Millions)
Figure 9. Anti-influenza Drugs in Adults
Figure 10. Global Anti-influenza Drugs Market: Adults (2017-2022) & ($ Millions)
Figure 11. Anti-influenza Drugs in Elderly
Figure 12. Global Anti-influenza Drugs Market: Elderly (2017-2022) & ($ Millions)
Figure 13. Global Anti-influenza Drugs Market Size Market Share by Application in 2021
Figure 14. Global Anti-influenza Drugs Revenue Market Share by Player in 2021
Figure 15. Global Anti-influenza Drugs Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Anti-influenza Drugs Market Size 2017-2022 ($ Millions)
Figure 17. APAC Anti-influenza Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Europe Anti-influenza Drugs Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Anti-influenza Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Americas Anti-influenza Drugs Value Market Share by Country in 2021
Figure 21. Americas Anti-influenza Drugs Consumption Market Share by Type in 2021
Figure 22. Americas Anti-influenza Drugs Market Size Market Share by Application in 2021
Figure 23. United States Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Anti-influenza Drugs Market Size Market Share by Region in 2021
Figure 28. APAC Anti-influenza Drugs Market Size Market Share by Application in 2021
Figure 29. China Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Anti-influenza Drugs Market Size Market Share by Country in 2021
Figure 36. Europe Anti-influenza Drugs Market Size Market Share by Type in 2021
Figure 37. Europe Anti-influenza Drugs Market Size Market Share by Application in 2021
Figure 38. Germany Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Application in 2021
Figure 46. Egypt Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Anti-influenza Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 52. APAC Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 53. Europe Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 55. United States Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Canada Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 59. China Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Japan Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 61. Korea Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 63. India Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Australia Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 65. Germany Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 66. France Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 67. UK Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Italy Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Russia Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Spain Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Israel Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Anti-influenza Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
